The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Open accessAbstract
Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (k app) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ABE8e has an “editing window,” the nucleotides accessible for deamination, of positions 4–9 in the protospacer (11–16 bases upstream from the PAM).16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, accumulative studies have proved that sgRNA-independent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O'Geen et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ABE8e, a variant published in 2020, exhibits a 590-fold increase in activity due to numerous mutations in the TadA deaminase domain.16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Truncated gRNA: truncated by 2-3bp at 5’ end | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Extended gRNA: GGX20 | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Self-citationClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04768-7 · Cited by 2,103
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Self-citationCRISPResso2 provides accurate and rapid genome editing sequence analysis
Clement, K., Rees, H. A., Canver, M. C., Gehrke, J. M., Farouni, R., Hsu, J. Y., Cole, M. A., Liu, D. R., Joung, J. K., Bauer, D. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0032-3 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,000
Emerging CRISPR Therapies for Precision Gene Editing and Modulation in the Cardiovascular Clinic
Legere, N., & Hinson, J. T. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02125-3 · Cited by 8
Konishi, C. T., Mulaiese, N., Butola, T., Zhang, Q., Kagan, D., Yang, Q., Pressler, M., Dirvin, B. G., Devinsky, O., Basu, J., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102441 · Cited by 6
In vivo adenine base editing ameliorates Rho-associated autosomal dominant retinitis pigmentosa
Hu, S., Chen, Y., Zhou, Y., Cao, T., Liu, S., Ding, C., Xie, D., Liang, P., Huang, L. T., Liu, H., et al. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.12.012 · Cited by 6
Improving adenine base editing precision by enlarging the recognition domain of CRISPR-Cas9
Gao, S., Weng, B., Wich, D., Power, L. H., Chen, M., Guan, H., Ye, Z., Xu, C., & Xu, Q. (2025) · Nature Communications · doi:10.1038/s41467-025-57154-5 · Cited by 7
Sokirniy, I., Inam, H., Tomaszkiewicz, M., Reynolds, J., McCandlish, D. M., & Pritchard, J. R. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf738 · Cited by 6
Wang, J., Dong, Q., Li, Y., Hu, L., Jia, C., Li, H., He, H., & Fan, C. (2025) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiaf467 · Cited by 6
Targeted BDNF upregulation via upstream open reading frame disruption
Ning, F., Goedert, T., Svrzikapa, N., Yan, D., Friedrichsen, H. J., Hanson, B., Ljungdahl, A., Dafinca, R., Talbot, K., Sanders, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.024 · Cited by 6
New and novel genetic tools for improving crops
Suprasanna, P., Saddhe, A. A., Ghuge, S. A., & Ingle, K. P. (2021) · CABI Reviews · doi:10.1079/pavsnnr202116028 · Cited by 7
Combined Theoretical, Bioinformatic, and Biochemical Analyses of RNA Editing by Adenine Base Editors
Rallapalli, K. L., Ranzau, B. L., Ganapathy, K. R., Paesani, F., & Komor, A. C. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0131 · Cited by 7
Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System
Devaraju, N., Rajendiran, V., Ravi, N. S., & Mohankumar, K. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_20 · Cited by 6
Production of MSTN knockout porcine cells using adenine base-editing-mediated exon skipping
Yang, S.-P., Zhu, X., Qu, Z.-X., Chen, C.-Y., Wu, Y.-B., Wu, Y., Luo, Z.-D., Wang, X., He, C.-Y., Fang, J.-W., et al. (2023) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-023-00763-5 · Cited by 6
Self-citationCRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy
Huang, L., Yang, C., Chen, Y., Deng, H., Liao, Z., & Xiao, H. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.045 · Cited by 7
Canadian Regulatory Framework and Regulatory Requirements for Cell and Gene Therapy Products
Wang, J., Griffiths, E., Tounekti, O., Nemec, M., Deneault, É., Lavoie, J. R., & Ridgway, A. A. G. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-34567-8_6 · Cited by 7
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects
Sahu, S., Poplawska, M., Lim, S. H., & Dutta, D. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122165 · Cited by 9
Ding, T., Liang, Z., Yang, Y., Liu, J., Li, W., Du, Y., Chen, Z., & Huo, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152076 · Cited by 6
Versatile and efficient genome editing with Neisseria cinerea Cas9
Liu, Z., Chen, S., Xie, W., Yu, H., Lai, L., & Li, Z. (2022) · Communications Biology · doi:10.1038/s42003-022-04258-z · Cited by 7
Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editors
Zhao, Y., Li, M., Liu, J., Xue, X., Zhong, J., Lin, J., Ye, B., Chen, J., & Qiao, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.055 · Cited by 6
In situ targeted mutagenesis of gut bacteriaPreprint
Brödel, A. K., Charpenay, L. H., Galtier, M., Fuche, F. J., Terrasse, R., Poquet, C., Arraou, M., Prevot, G., Spadoni, D., Hessel, E. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.30.509847 · Cited by 6
One-round-per-day CRISPR genome editing of E. coli for engineering green-chemical overproducer
Liang, Z., Ye, Z., Xia, Y., Du, X., Sun, L., Ma, X., Guo, S., & Huo, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158453 · Cited by 5
From IscB to Cas9: Engineering and advances in the next generation of miniature gene editing tools
Zhou, C., Zhu, S., Luo, C., Wang, W., Fan, H.-Q., Gao, Y., Xu, X., Wang, Q., Yu, Y., & Xie, T. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108743 · Cited by 5
Targeted Intracellular Delivery via Precision Programming of ARRDC1‐Mediated Microvesicles
Qiao, Z., Choi, S., Chen, Z., Rodriguez, R. M., Wang, Q., Yang, Z., Theuerkauf, S. A., Nabhan, J. F., Hensch, T. K., Buchholz, C. J., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70199 · Cited by 6
Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs
Almufarriji, F. M. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-026-00064-4 · Cited by 5
Advances in Engineered Virus-Like Particles for Genome Editing and Therapy
Son, S. H., Woo, S., Choi, A., Ahn, S., & Yoo, H. C. (2026) · BioDrugs · doi:10.1007/s40259-026-00767-z · Cited by 5
Precise, minimally evolved adenine base editors generated through mutation reversion analysis
Evanoff, M., Korpal, S., Krill, Z. D., Cowan, Q. T., & Komor, A. C. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03045-z · Cited by 5
Precision genome editing with DNA base editors
Mawson, S. J., Dunne-Dombrink, K., Pollak, B. R., & Komor, A. C. (2026) · Nature Reviews Methods Primers · doi:10.1038/s43586-026-00478-3 · Cited by 8
AI ‐designed OpenCRISPR ‐1 performs robust knockout, base editing, and prime editing in rice
Das, P., Saha, R., Panda, D., Ghosh, C., Avinash, S. P., Panda, S., Baig, M. J., & Molla, K. A. (2026) · New Phytologist · doi:10.1111/nph.71272 · Cited by 7
Plant Mutagenesis Tools for Precision Breeding: Conventional CRISPR/Cas9 Tools and Beyond
Shelake, R. M., Pramanik, D., Waghunde, R. R., & Kim, J. (2023) · Springer eBooks · doi:10.1007/978-981-16-9720-3_10 · Cited by 6
Expanding the targeting scope of CRISPR/Cas9-mediated genome editing by Cas9 variants in Brassica
Li, W., Li, X., Wang, C., Huo, G., Zhang, X., Yu, J., Yu, X., Li, J., Zhang, C., Zhao, J., et al. (2024) · aBIOTECH · doi:10.1007/s42994-024-00155-7 · Cited by 5
Advancing CRISPR base editing technology through innovative strategies and ideas
Fan, X., Lei, Y., Wang, L., Wu, X., & Li, D. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2699-5 · Cited by 5
Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2
Ging, K., Frick, L. D., Schlachetzki, J. C. M., Armani, A., Zhu, Y., Gilormini, P., Dhingra, A., Böck, D., Marques, A., Deen, M. C., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00819-7 · Cited by 5
Development and optimization of base editors and its application in crops
Jiang, C., Li, Y., Wang, R., Sun, X., Zhang, Y., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150942 · Cited by 7
Kinney, K. J., Jia, K., Zhang, H., Schmaljohn, E., Osborne, T., Thommandru, B., Murugan, K., Peña, A. S., West, S. C., Chen, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74623-7 · Cited by 6
Xu, K., Hua, G., Wu, M., Zhang, H., Liu, J., Hu, F., & Zuo, E. (2025) · Cell Research · doi:10.1038/s41422-025-01164-x · Cited by 6
Gupta, D., Patinios, C., Bassett, H. V., Kibe, A., Collins, S. P., Kamm, C., Wang, Y., Zhao, C., Vollen, K., Toussaint, C., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02802-w · Cited by 5
Oliynyk, R. T., Mahas, A., Karpinski, E., & Church, G. M. (2025) · Communications Biology · doi:10.1038/s42003-025-09157-7 · Cited by 5
Xing, S., Sun, Y., Li, B., Li, H., Zhao, K. T., Chen, K., & Gao, C. (2022) · National Science Open · doi:10.1360/nso/20220052 · Cited by 5
Self-citationScanning mutagenesis of the voltage-gated sodium channel NaV1.2 using base editing
Pablo, J. L., Cornett, S. L., Wang, L. A., Jo, S., Brünger, T., Budnik, N., Hegde, M., DeKeyser, J., Thompson, C. H., Doench, J. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112563 · Cited by 5
Revolutionizing genetic disease treatment: Recent technological advances in base editing
Daniel, T. C., Zeng, H., Osikpa, E. C., & Gao, X. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100472 · Cited by 6
Protein engineering technologies for development of next-generation genome editors
Winter, J., Shirguppe, S., & Pérez‐Piñera, P. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100514 · Cited by 5
Adenine base editor–mediated splicing remodeling activates noncanonical splice sites
Liu, Y., Li, Q., Yan, T., Chen, H., Wang, J., Wang, Y., Yang, Y., Xiang, L., Chi, Z., Ren, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105442 · Cited by 5
Bär, I., Barraclough, A., Bürgisser, P. E., van Kwawegen, C. B., Fijnvandraat, K., Eikenboom, J. C. J., Leebeek, F. W. G., Voorberg, J., & Bierings, R. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.10.023 · Cited by 5
The Development and Application of a Base Editor in Biomedicine
Wang, F., Zeng, Y., Wang, Y., & Niu, Y. (2020) · BioMed Research International · doi:10.1155/2020/2907623 · Cited by 5
Advances in base editing with an emphasis on an AAV-based strategy
Kuang, J., Lyu, Q., Wang, J., Cui, Y., & Zhao, J. (2021) · Methods · doi:10.1016/j.ymeth.2021.03.015 · Cited by 5
Systematicidentification of CRISPR off-target effects by CROss-seq
Li, Y., Zhi, S., Wu, T., Chen, H.-X., Kang, R., Ma, D.-Z., Songyang, Z., He, C., Liang, P., & Luo, G. (2022) · Protein & Cell · doi:10.1093/procel/pwac018 · Cited by 5
Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient
Elsayed, M. E. A. A., Kaukonen, M. K., Kiraly, P., Cehajic‐Kapetanovic, J., & MacLaren, R. E. (2022) · Genes · doi:10.3390/genes13112103 · Cited by 6
Quantification of evolved DNA-editing enzymes at scale with DEQSeq
Schmitt, L. T., Schneider, A., Posorski, J., Lansing, F., Jelicic, M., Jain, M., Sayed, S., Buchholz, F., & Sürün, D. (2023) · Genome biology · doi:10.1186/s13059-023-03097-3 · Cited by 5
Tan, W. Z., Wang, Z., & Liu, L. (2024) · Agriculture · doi:10.3390/agriculture15010029 · Cited by 5
Huang, Y., Ma, K., Li, Y., Li, Q., Lu, F., Zhang, X., & Sun, Z. (2025) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2025.06.008 · Cited by 4
exoCasMINI: A T5 exonuclease fused CRISPR-Cas12f system with enhanced gene editing efficiency
Liao, K., Chen, K., Ma, S., Yang, X., Chen, P., Li, S., Li, M., Zhang, X., & Lin, Y. (2025) · iScience · doi:10.1016/j.isci.2025.113171 · Cited by 4
Carpenter, M. D., Kus, N. J., Choi, R. B., Said, H., Dumitru, A. M., Bauer, J. H., Wang, S., Luks, V. L., Teerdhala, S., Shah, A., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101599 · Cited by 7
Tools and delivery technologies for mitochondrial gene editing
Li, N., Wu, B., Xiao, Y., Hao, Y., Wu, F., Wei, Y., Xu, Y., & Han, X. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100254 · Cited by 4
Zhu, H., Wang, L., Wang, Y., Jiang, X., Qin, Q., Song, M., & Huang, Q. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05263-7 · Cited by 6
Zhou, Z., Wang, Y., Zheng, X., Zhang, X., Ji, L., Han, J.-Y., Zuo, Z., Mo, W., & Zhang, L. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2707-9 · Cited by 4
Biotechnological applications of purine and pyrimidine deaminases
Arco, J. D., Acosta, J., & Fernández‐Lucas, J. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108473 · Cited by 4
DNA‐free base editing in lettuce via in vitro transcribed base editors
Lee, E., Kim, Y., Kim, M., Lee, D., & Kang, B. (2024) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13822 · Cited by 4
Chen, C., Li, Y., Gu, Y., Zhai, Q., Guo, S., Xiang, J., Xie, Y., An, M., Li, C., Qin, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56725-w · Cited by 4
Yamamoto, Y., Chua, K., Staudt, D., Ferrasse, A., Kirillova, A., Jong, H. N. D., Floyd, B. J., Cadisch, C., Wiel, L., Wang, Q., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.075535 · Cited by 4
Engineered Cas12j‐8 is a Versatile Platform for Multiplexed Genome Modulation in Mammalian Cells
Meng, R., Li, J., Wang, W., Liang, D., Li, Z., Mao, C., Li, Q., Zhang, Y., Chen, H., Tang, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202502593 · Cited by 4
Jeong, Y. Y., Han, J. H., Yu, J., Bae, S., & Seo, P. J. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0102 · Cited by 4
He, Z., Xie, Y., Huang, H., Zhang, Z., Feng, S., Xu, R., Chen, X., Gao, F., Li, P., Zhu, M., et al. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.08.003 · Cited by 4
CRISPR libraries: A powerful screening tool for function and mechanism study of cancer
Jia, C., Liang, Z., Yao, X., Lin, Q., & Zhang⋆, Y. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100044 · Cited by 6
Zhang, H., Wan, Z., Li, X., Wang, B., Guan, J., Li, Y., Jin, X., Ma, X., & Liu, G. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04630-w · Cited by 4
Efficient glycosylase-mediated base editing with minimal off-target effects in mammalian embryos
Wei, Y., Cao, X., Huang, S., Yang, Y., Luo, M., Liu, Z., Liu, B., Zhang, Q., Wu, Y., Wang, L., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03838-6 · Cited by 6
Base editing strategies for in vivo correction of two highly recurrent phenylketonuria variants
Quigley, A., Jindal, I., Campion, T., Rutherford, D. V., Han, Y., Quigley, W., Qü, P., Musunuru, K., Ahrens‐Nicklas, R. C., Hong, X., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102770 · Cited by 4
Zhang, F., Peng, Y., Fan, D., Song, G., Gao, X., & Tian, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-65724-w · Cited by 5
Protein-nucleic acid language model-assisted design of precise and compact adenine base editor
Ren, J., Yao, J.-W., Cao, Q., Li, Y.-N., Li, Y., Zhang, Z., Ge, X., Wang, S.-F., Zhang, Y., Wang, X.-G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65311-z · Cited by 4
Mu, S., Li, Q., Chen, M., Li, Z., Ma, Y., Li, Y., Song, Y., Hou, S., Ding, Y., Ju, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68469-2 · Cited by 4
Zhang, C., Li, J., Li, Y., Yan, L., Yong, C. S. Y., Li, S., He, Y., & Xia, L. (2026) · Journal of Integrative Plant Biology · doi:10.1111/jipb.70154 · Cited by 4
Reever, C. M., Boscia, A. R., Deutsch, T. C. J., Patel, M. P., Miralles, R. M., Kittur, S., Fleischel, E. J., Buo, A. M., Yorek, M. S., Meisler, M. H., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196402 · Cited by 7
Ablation of PKCα Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure
Tadokoro, T., Li, H., Gan, P., Xu, Z., Tan, W. H., Alzhanov, D., Sanchez‐Ortiz, E., McAnally, J., Guo, L., Xu, L., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326738 · Cited by 4
Vasquez, C. A., Evanoff, M., Ranzau, B. L., Gu, S., Deters, E., & Komor, A. C. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0002 · Cited by 4
Fueling next-generation genome editing with DNA repair
Gvozdenovic, A., & Corn, J. E. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100506 · Cited by 5
Nucleoside deaminases: the key players in base editing toolkit
Xiang, J., Xu, W., Wu, J., Luo, Y., Yang, B., & Chen, J. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230029 · Cited by 4
Chen, S., Lo, C., Liu, Z., Wang, Q. K., Ning, K., Li, T., & Sun, Y. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae045 · Cited by 4
Genome-Wide A → G and C → T Mutations Induced by Functional TadA Variants in Escherichia coli
Wang, H., Dong, Z., Shi, J., Chen, L., Sun, T., & Zhang, W. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00597 · Cited by 4
Precise somatic genome editing for treatment of inborn errors of immunity
Meng, Q., Sun, H., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960348 · Cited by 4
Tang, N., Wu, Z., Gao, Y., Chen, W., Wang, Z., Su, M., Ji, W., & Ji, Q. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00501 · Cited by 4
Base editing screens map mutations affecting IFNγ signalling in cancerPreprint
Coelho, M. A., Karakoç, E., Bhosle, S. G., Gonçalves, E., Burgold, T., Cooper, S., Cattaneo, C. M., Veninga, V., Consonni, S., Dinçer, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.29.486051 · Cited by 4
Systematic optimization of Cas12a base editors in wheat and maize using the ITER platformPreprint
Gaillochet, C., Fernández, A. P., Goossens, V., D’Halluin, K., Drozdzecki, A., Shafie, M., Duyse, J. V., Isterdael, G. V., Gonzalez, C., Vermeersch, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.11.491340 · Cited by 4
How CRISPR Is Revolutionizing the Generation of New Models for Cancer ResearchPreprint
Rivera, F. J. S., & Dow, L. E. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041384 · Cited by 4
RNA-DNA hybrid binding domain broadens the editing window of base editors
Yang, Y., Fu, Z., Deng, S., Wu, G., Wang, C., Luo, X., Kang, R., Chen, Y., Peng, C., Zhang, P., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.024 · Cited by 4
Qin, W., Lin, S., Zhang, Y., Huang, K., Petree, C., Boyd, K. A., Varshney, P., & Varshney, G. K. (2025) · Advanced Science · doi:10.1002/advs.202509800 · Cited by 3
Tafech, B., Carlaw, T., Sadhnani, G., Schmidt, K., Morin, T., Leung, J., Weiner, J. M., An, K., Balázs, A., Ross, C. J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114053 · Cited by 6
Wang, P., Sen, R., Buchholz, F., & Sayed, S. (2025) · Genome biology · doi:10.1186/s13059-025-03667-7 · Cited by 5
CRISPR/Cas-Based Ex Vivo Gene Therapy and Lysosomal Storage Disorders: A Perspective Beyond Cas9
Leal, A. F., Prieto, L. E., & Pachajoa, H. (2025) · Cells · doi:10.3390/cells14151147 · Cited by 4
Spatial profiling of gene editing by in situ sequencing in mice and macaques
Janjuha, S., Haenggi, T., Chamberlain, T. C., Rothgangl, T., Kissling, L., Wilhelm, M., Mathis, N., Böck, D., Marquart, K. F., Ioannidi, E. I., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01512-7 · Cited by 3
Gene therapy for inborn errors of immunity: past progress, current status and future directions
Torrance, R. W., Orf, K., & Fox, T. A. (2025) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2025.42 · Cited by 5
Continuous targeted hypermutation with a tunable mutation window
Lee, C., & Kim, S. (2025) · Nature Communications · doi:10.1038/s41467-025-66736-2 · Cited by 3
Engineering with care: safety assessment platforms for CRISPR-modified natural killer cells
Fazeli, A., Ullrich, E., Cathomen, T., & Bexte, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711414 · Cited by 3
Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing
Chen, Q., Gou, H., Xu, C., Wang, S., Zhang, H., Song, M., Wang, M., Ji, X., Wei, X., Tan, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202516670 · Cited by 3
Overview of gene editing strategies against HBV
Janetzki, Z. T., McCoullough, L. C., Revill, P. A., & Littlejohn, M. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106355 · Cited by 4
Non-viral delivery of genome-editing tools for treatment of genetic disorders
Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3
Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model
Zhang, Z., Wang, M., Tan, F., Zhang, L., Wang, X., Chen, X., Han, J., Li, N., Sun, Q., Lu, Y., et al. (2026) · Med · doi:10.1016/j.medj.2026.101001 · Cited by 4
In vitro and in vivo base editing of CCR5 in hematopoietic stem cells confers HIV-1 resistance
Anderson, A. K., Georgakopoulou, A., Kuhlmann, A.-S., Wang, H., Riker, A. O., Karuppusamy, K. V., Radtke, S., Bui, J. K., Kiem, H., Lieber, A., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.018 · Cited by 3
Omega-based mini prime- and base-editing systems in Escherichia coli
Liu, L.-H., Zhang, Y., Bo, X. U., YunXia, L. I., Guo, Y., Lu, X., Zhang, Z., Lai, S., Ge, Q., Zhang, K., et al. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.02.002 · Cited by 3
Enhancing CRISPR‐Cas12a base editing in plants with LbCas12a variants and introns
Cheng, Y., Li, G., Zhou, M., Mandlik, R., Wang, D., & Qi, Y. (2026) · Journal of Integrative Plant Biology · doi:10.1111/jipb.70249 · Cited by 3
Advances in in vivo continuous evolution technologies for strain development and enzyme engineering
Yuan, L., Gao, C., Li, X., Hu, G., Song, W. G., Wei, W., & Wu, J. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108895 · Cited by 3
Lei, L., Kaufmann, M. M., Lao, J., Thoulass, G., Ammann, S., Xiao, H., Rhiel, M., Dettmer‐Monaco, V., Grünewald, J., Andrieux, G., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.014 · Cited by 6
Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders
Ren, X., Zhou, Z., Kong, L., Guo, Y., Liu, Y., Li, J., Gu, X., Jiang, C., & Wu, J. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108921 · Cited by 3
Sun, Y., Pien, Y.-C., Xiao, Y., Tan, W. H., Sanchez‐Ortiz, E., Durbacz, M. Z., Chen, Z., McAnally, J., Zhang, Y., Li, H., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528477123 · Cited by 4
Metadata
- Authors
- Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., Doudna, J. A., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-03-16
- Volume
- 38
- Issue
- 7
- Pages
- 883-891
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7357821
- OpenAlex
- W3012327875
- Cited by
- 1,020
- References
- 60
- Citations by year
- 2026: 158 · 2025: 196 · 2024: 192 · 2023: 192 · 2022: 148 · 2021: 103 · 2020: 29
- FWCI
- 38.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-20)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- adenine base editing, ABE8e, phage-assisted continuous evolution, Cas12, processivity, off-target editing, fetal hemoglobin, PAM site
- MeSH terms
- Gene Editing, Adenine, Adenosine Deaminase, Bacteriophages, DNA, Humans, Mutation, RNA, Mutagenesis, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
